tiprankstipranks
Trending News
More News >
Biomea Fusion (BMEA)
NASDAQ:BMEA
US Market

Biomea Fusion (BMEA) Stock Forecast & Price Target

Compare
761 Followers
See the Price Targets and Ratings of:

BMEA Analyst Ratings

Strong Buy
5Ratings
Strong Buy
4 Buy
1 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Biomea
Fusion
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BMEA Stock 12 Month Forecast

Average Price Target

$13.60
▲(455.10%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Biomea Fusion in the last 3 months. The average price target is $13.60 with a high forecast of $30.00 and a low forecast of $3.00. The average price target represents a 455.10% change from the last price of $2.45.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","31":"$31","7.75":"$7.75","15.5":"$15.5","23.25":"$23.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,7.75,15.5,23.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.55,3.7384615384615385,5.926923076923076,8.115384615384615,10.303846153846154,12.492307692307692,14.68076923076923,16.869230769230768,19.057692307692307,21.246153846153845,23.434615384615384,25.623076923076923,27.811538461538458,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.55,2.476923076923077,3.4038461538461537,4.3307692307692305,5.257692307692308,6.184615384615384,7.111538461538461,8.038461538461538,8.965384615384615,9.892307692307693,10.819230769230769,11.746153846153845,12.673076923076923,{"y":13.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.55,1.6615384615384616,1.773076923076923,1.8846153846153846,1.9961538461538462,2.1076923076923078,2.2192307692307693,2.3307692307692305,2.4423076923076925,2.5538461538461537,2.6653846153846157,2.776923076923077,2.8884615384615384,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.57,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.52,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.42,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.33,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.04,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.88,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$30.00Average Price Target$13.60Lowest Price Target$3.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on BMEA
Edward TenthoffPiper Sandler
Piper Sandler
$7
Buy
185.71%
Upside
Initiated
06/03/25
Biomea Fusion assumed with an Overweight at Piper SandlerBiomea Fusion assumed with an Overweight at Piper Sandler
Scotiabank Analyst forecast on BMEA
George FarmerScotiabank
Scotiabank
$30
Buy
1124.49%
Upside
Reiterated
05/06/25
Biomea Fusion (BMEA) Receives a Buy from Scotiabank
Barclays Analyst forecast on BMEA
Peter LawsonBarclays
Barclays
$3
Hold
22.45%
Upside
Reiterated
05/06/25
Biomea Fusion (BMEA) Receives a Hold from Barclays
Oppenheimer Analyst forecast on BMEA
Matthew BieglerOppenheimer
Oppenheimer
$10
Buy
308.16%
Upside
Reiterated
05/06/25
Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), Biomea Fusion (BMEA)
H.C. Wainwright Analyst forecast on BMEA
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$40$18
Buy
634.69%
Upside
Reiterated
05/06/25
Analysts Conflicted on These Healthcare Names: Biomea Fusion (NASDAQ: BMEA) and Quest Diagnostics (NYSE: DGX)
D. Boral Capital Analyst forecast on BMEA
Jason KolbertD. Boral Capital
D. Boral Capital
$128$16
Buy
553.06%
Upside
Reiterated
01/13/25
Biomea Fusion price target lowered to $16 from $128 at D. Boral CapitalBiomea Fusion price target lowered to $16 from $128 at D. Boral Capital
Truist Financial Analyst forecast on BMEA
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Assigned
12/18/24
Biomea Fusion (BMEA) Receives a Buy from Truist Financial
J.P. Morgan Analyst forecast on BMEA
Eric JosephJ.P. Morgan
J.P. Morgan
$11
Hold
348.98%
Upside
Reiterated
12/17/24
Cautious Hold Rating on Biomea Fusion Amid Uncertainties in Drug Efficacy and Financial Outlook
Citi
$22
Buy
797.96%
Upside
Reiterated
11/25/24
we maintain our Buy/High Risk rating.
Capital One Financial Analyst forecast on BMEA
Naureen QuibriaCapital One Financial
Capital One Financial
$25
Buy
920.41%
Upside
Reiterated
09/27/24
Analysts Offer Insights on Healthcare Companies: Adverum Biotechnologies (NASDAQ: ADVM), Biomea Fusion (NASDAQ: BMEA) and Travere Therapeutics (NASDAQ: TVTX)
Rodman & Renshaw Analyst forecast on BMEA
Anthony ButlerRodman & Renshaw
Rodman & Renshaw
$18
Buy
634.69%
Upside
Upgraded
09/26/24
Biomea Fusion upgraded to Buy from Neutral at Rodman & RenshawBiomea Fusion upgraded to Buy from Neutral at Rodman & Renshaw
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on BMEA
Edward TenthoffPiper Sandler
Piper Sandler
$7
Buy
185.71%
Upside
Initiated
06/03/25
Biomea Fusion assumed with an Overweight at Piper SandlerBiomea Fusion assumed with an Overweight at Piper Sandler
Scotiabank Analyst forecast on BMEA
George FarmerScotiabank
Scotiabank
$30
Buy
1124.49%
Upside
Reiterated
05/06/25
Biomea Fusion (BMEA) Receives a Buy from Scotiabank
Barclays Analyst forecast on BMEA
Peter LawsonBarclays
Barclays
$3
Hold
22.45%
Upside
Reiterated
05/06/25
Biomea Fusion (BMEA) Receives a Hold from Barclays
Oppenheimer Analyst forecast on BMEA
Matthew BieglerOppenheimer
Oppenheimer
$10
Buy
308.16%
Upside
Reiterated
05/06/25
Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), Biomea Fusion (BMEA)
H.C. Wainwright Analyst forecast on BMEA
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$40$18
Buy
634.69%
Upside
Reiterated
05/06/25
Analysts Conflicted on These Healthcare Names: Biomea Fusion (NASDAQ: BMEA) and Quest Diagnostics (NYSE: DGX)
D. Boral Capital Analyst forecast on BMEA
Jason KolbertD. Boral Capital
D. Boral Capital
$128$16
Buy
553.06%
Upside
Reiterated
01/13/25
Biomea Fusion price target lowered to $16 from $128 at D. Boral CapitalBiomea Fusion price target lowered to $16 from $128 at D. Boral Capital
Truist Financial Analyst forecast on BMEA
Srikripa DevarakondaTruist Financial
Truist Financial
Buy
Assigned
12/18/24
Biomea Fusion (BMEA) Receives a Buy from Truist Financial
J.P. Morgan Analyst forecast on BMEA
Eric JosephJ.P. Morgan
J.P. Morgan
$11
Hold
348.98%
Upside
Reiterated
12/17/24
Cautious Hold Rating on Biomea Fusion Amid Uncertainties in Drug Efficacy and Financial Outlook
Citi
$22
Buy
797.96%
Upside
Reiterated
11/25/24
we maintain our Buy/High Risk rating.
Capital One Financial Analyst forecast on BMEA
Naureen QuibriaCapital One Financial
Capital One Financial
$25
Buy
920.41%
Upside
Reiterated
09/27/24
Analysts Offer Insights on Healthcare Companies: Adverum Biotechnologies (NASDAQ: ADVM), Biomea Fusion (NASDAQ: BMEA) and Travere Therapeutics (NASDAQ: TVTX)
Rodman & Renshaw Analyst forecast on BMEA
Anthony ButlerRodman & Renshaw
Rodman & Renshaw
$18
Buy
634.69%
Upside
Upgraded
09/26/24
Biomea Fusion upgraded to Buy from Neutral at Rodman & RenshawBiomea Fusion upgraded to Buy from Neutral at Rodman & Renshaw
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biomea Fusion

1 Month
xxx
Success Rate
4/7 ratings generated profit
57%
Average Return
+4.30%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +4.30% per trade.
3 Months
xxx
Success Rate
3/7 ratings generated profit
43%
Average Return
-7.23%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -7.23% per trade.
1 Year
Matthew BieglerOppenheimer
Success Rate
2/7 ratings generated profit
29%
Average Return
-28.29%
reiterated a buy rating last month
Copying Matthew Biegler's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -28.29% per trade.
2 Years
xxx
Success Rate
2/7 ratings generated profit
29%
Average Return
-28.29%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -28.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BMEA Analyst Recommendation Trends

Rating
Jan 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
12
13
9
9
6
Buy
1
1
0
0
0
Hold
5
6
3
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
20
12
12
8
In the current month, BMEA has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BMEA average Analyst price target in the past 3 months is 13.60.
Each month's total comprises the sum of three months' worth of ratings.

BMEA Financial Forecast

BMEA Earnings Forecast

Next quarter’s earnings estimate for BMEA is -$0.57 with a range of -$0.80 to -$0.21. The previous quarter’s EPS was -$0.81. BMEA beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year BMEA has Outperformed its overall industry.
Next quarter’s earnings estimate for BMEA is -$0.57 with a range of -$0.80 to -$0.21. The previous quarter’s EPS was -$0.81. BMEA beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year BMEA has Outperformed its overall industry.
No data currently available

BMEA Sales Forecast

Next quarter’s sales forecast for BMEA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. BMEA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year BMEA has Preformed in-line its overall industry.
Next quarter’s sales forecast for BMEA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were ―. BMEA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year BMEA has Preformed in-line its overall industry.

BMEA Stock Forecast FAQ

What is BMEA’s average 12-month price target, according to analysts?
Based on analyst ratings, Biomea Fusion’s 12-month average price target is 13.60.
    What is BMEA’s upside potential, based on the analysts’ average price target?
    Biomea Fusion has 455.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BMEA a Buy, Sell or Hold?
          Biomea Fusion has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Biomea Fusion’s price target?
            The average price target for Biomea Fusion is 13.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $30.00 ,the lowest forecast is $3.00. The average price target represents 455.10% Increase from the current price of $2.45.
              What do analysts say about Biomea Fusion?
              Biomea Fusion’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of BMEA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis